Skip to contentE
Escalon Medical Corp
E
ESMCEscalon Medical Corp Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$3.14M$3.14Mderived+7.7% vs Q4 2022 Net Income$198.36K$198.36Kderived+165.4% vs Q4 2022 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$204,887+269.9% Operating Cash Flowderived$354,927N/M Free Cash Flowderived$354,927N/M Margins · derivedOperating margin6.5%+4.6 pt vs Q4 2022
Net margin6.3%+3.8 pt vs Q4 2022
ended Jun 30, 2023 · filed Oct 13, 2023 · 105 d after period end